Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 29 entries
Sorted by: Best Match Show Resources per page
Current challenges facing the assessment of the allergenic capacity of food allergens in animal models.

Clinical and translational allergy

Bøgh KL, van Bilsen J, Głogowski R, López-Expósito I, Bouchaud G, Blanchard C, Bodinier M, Smit J, Pieters R, Bastiaan-Net S, de Wit N, Untersmayr E, Adel-Patient K, Knippels L, Epstein MM, Noti M, Nygaard UC, Kimber I, Verhoeckx K, O'Mahony L.
PMID: 27313841
Clin Transl Allergy. 2016 Jun 16;6:21. doi: 10.1186/s13601-016-0110-2. eCollection 2016.

Food allergy is a major health problem of increasing concern. The insufficiency of protein sources for human nutrition in a world with a growing population is also a significant problem. The introduction of new protein sources into the diet,...

Cite
Bøgh KL, van Bilsen J, Głogowski R, et al. Current challenges facing the assessment of the allergenic capacity of food allergens in animal models. Clin Transl Allergy. 2016;6:21doi: 10.1186/s13601-016-0110-2.
Bøgh, K. L., van Bilsen, J., Głogowski, R., López-Expósito, I., Bouchaud, G., Blanchard, C., Bodinier, M., Smit, J., Pieters, R., Bastiaan-Net, S., de Wit, N., Untersmayr, E., Adel-Patient, K., Knippels, L., Epstein, M. M., Noti, M., Nygaard, U. C., Kimber, I., Verhoeckx, K., & O'Mahony, L. (2016). Current challenges facing the assessment of the allergenic capacity of food allergens in animal models. Clinical and translational allergy, 621. https://doi.org/10.1186/s13601-016-0110-2
Bøgh, Katrine Lindholm, et al. "Current challenges facing the assessment of the allergenic capacity of food allergens in animal models." Clinical and translational allergy vol. 6 (2016): 21. doi: https://doi.org/10.1186/s13601-016-0110-2
Bøgh KL, van Bilsen J, Głogowski R, López-Expósito I, Bouchaud G, Blanchard C, Bodinier M, Smit J, Pieters R, Bastiaan-Net S, de Wit N, Untersmayr E, Adel-Patient K, Knippels L, Epstein MM, Noti M, Nygaard UC, Kimber I, Verhoeckx K, O'Mahony L. Current challenges facing the assessment of the allergenic capacity of food allergens in animal models. Clin Transl Allergy. 2016 Jun 16;6:21. doi: 10.1186/s13601-016-0110-2. eCollection 2016. PMID: 27313841; PMCID: PMC4910256.
Copy Download .nbib Format: NLM
Watch and wait after a clinical complete response in rectal cancer patients younger than 50 years.

The British journal of surgery

Bahadoer RR, Peeters KCMJ, Beets GL, Figueiredo NL, Bastiaannet E, Vahrmeijer A, Temmink SJD, Meershoek-Klein Kranenbarg WME, Roodvoets AGH, Habr-Gama A, Perez RO, van de Velde CJH, Hilling DE.
PMID: 34738104
Br J Surg. 2021 Dec 17;109(1):114-120. doi: 10.1093/bjs/znab372.

BACKGROUND: Young-onset rectal cancer, in patients less than 50 years, is expected to increase in the coming years. A watch-and-wait strategy is nowadays increasingly practised in patients with a clinical complete response (cCR) after neoadjuvant treatment. Nevertheless, there may...

Cite
Bahadoer RR, Peeters KCMJ, Beets GL, et al. Watch and wait after a clinical complete response in rectal cancer patients younger than 50 years. Br J Surg. 2021;109(1):114-120doi: 10.1093/bjs/znab372.
Bahadoer, R. R., Peeters, K. C. M. J., Beets, G. L., Figueiredo, N. L., Bastiaannet, E., Vahrmeijer, A., Temmink, S. J. D., Meershoek-Klein Kranenbarg, W. M. E., Roodvoets, A. G. H., Habr-Gama, A., Perez, R. O., van de Velde, C. J. H., Hilling, D. E. (2021). Watch and wait after a clinical complete response in rectal cancer patients younger than 50 years. The British journal of surgery, 109(1), 114-120. https://doi.org/10.1093/bjs/znab372
Bahadoer, Renu R, et al. "Watch and wait after a clinical complete response in rectal cancer patients younger than 50 years." The British journal of surgery vol. 109,1 (2021): 114-120. doi: https://doi.org/10.1093/bjs/znab372
Bahadoer RR, Peeters KCMJ, Beets GL, Figueiredo NL, Bastiaannet E, Vahrmeijer A, Temmink SJD, Meershoek-Klein Kranenbarg WME, Roodvoets AGH, Habr-Gama A, Perez RO, van de Velde CJH, Hilling DE. Watch and wait after a clinical complete response in rectal cancer patients younger than 50 years. Br J Surg. 2021 Dec 17;109(1):114-120. doi: 10.1093/bjs/znab372. PMID: 34738104.
Copy Download .nbib Format: NLM
Competing risks in quality and safety research: a framework to guide choice of analysis and improve reporting.

BMJ quality & safety

Marang-van de Mheen PJ, Putter H, Bastiaannet E, Bottle A.
PMID: 34535557
BMJ Qual Saf. 2021 Dec;30(12):1031-1037. doi: 10.1136/bmjqs-2021-012988. Epub 2021 Sep 17.

When comparing hospitals on their readmission rates as currently done in the Hospital Readmission and Reduction Program (HRRP) in the USA, should we include the competing risk of mortality after discharge, which precludes the readmission, in the analysis? Not...

Cite
Marang-van de Mheen PJ, Putter H, Bastiaannet E, et al. Competing risks in quality and safety research: a framework to guide choice of analysis and improve reporting. BMJ Qual Saf. 2021;30(12):1031-1037doi: 10.1136/bmjqs-2021-012988.
Marang-van de Mheen, P. J., Putter, H., Bastiaannet, E., & Bottle, A. (2021). Competing risks in quality and safety research: a framework to guide choice of analysis and improve reporting. BMJ quality & safety, 30(12), 1031-1037. https://doi.org/10.1136/bmjqs-2021-012988
Marang-van de Mheen, Perla J, et al. "Competing risks in quality and safety research: a framework to guide choice of analysis and improve reporting." BMJ quality & safety vol. 30,12 (2021): 1031-1037. doi: https://doi.org/10.1136/bmjqs-2021-012988
Marang-van de Mheen PJ, Putter H, Bastiaannet E, Bottle A. Competing risks in quality and safety research: a framework to guide choice of analysis and improve reporting. BMJ Qual Saf. 2021 Dec;30(12):1031-1037. doi: 10.1136/bmjqs-2021-012988. Epub 2021 Sep 17. PMID: 34535557.
Copy Download .nbib Format: NLM
Chemoradiation and Local Excision versus Total Mesorectal Excision for T2N0 Rectal Cancer: Comparison of Short- and Long-Term Outcomes from Two Prospective Studies.

Annals of surgery

Lynn PB, Van der Valk M, Claassen YHM, Shi Q, Widmar M, Bastiaannet E, Van de Velde C, Garcia-Aguilar J.
PMID: 34225302
Ann Surg. 2021 Jul 02; doi: 10.1097/SLA.0000000000005052. Epub 2021 Jul 02.

OBJECTIVE: Compare oncological long-term and short-term outcomes between patients with distal cT2N0 rectal cancer treated with chemoradiotherapy and local excision (CRT+LE) and patients treated with total mesorectal excision (TME).SUMMARY BACKGROUND DATA: Previous studies showed that CRT+LE is equivalent to...

Cite
Lynn PB, Van der Valk M, Claassen YHM, et al. Chemoradiation and Local Excision versus Total Mesorectal Excision for T2N0 Rectal Cancer: Comparison of Short- and Long-Term Outcomes from Two Prospective Studies. Ann Surg. 2021;doi: 10.1097/SLA.0000000000005052.
Lynn, P. B., Van der Valk, M., Claassen, Y. H. M., Shi, Q., Widmar, M., Bastiaannet, E., Van de Velde, C., & Garcia-Aguilar, J. (2021). Chemoradiation and Local Excision versus Total Mesorectal Excision for T2N0 Rectal Cancer: Comparison of Short- and Long-Term Outcomes from Two Prospective Studies. Annals of surgery, . https://doi.org/10.1097/SLA.0000000000005052
Lynn, Patricio B, et al. "Chemoradiation and Local Excision versus Total Mesorectal Excision for T2N0 Rectal Cancer: Comparison of Short- and Long-Term Outcomes from Two Prospective Studies." Annals of surgery vol. (2021). doi: https://doi.org/10.1097/SLA.0000000000005052
Lynn PB, Van der Valk M, Claassen YHM, Shi Q, Widmar M, Bastiaannet E, Van de Velde C, Garcia-Aguilar J. Chemoradiation and Local Excision versus Total Mesorectal Excision for T2N0 Rectal Cancer: Comparison of Short- and Long-Term Outcomes from Two Prospective Studies. Ann Surg. 2021 Jul 02; doi: 10.1097/SLA.0000000000005052. Epub 2021 Jul 02. PMID: 34225302; PMCID: PMC8658950.
Copy Download .nbib Format: NLM
Four different treatment strategies in aggressive fibromatosis: A systematic review.

Clinical and translational radiation oncology

Seinen JM, Niebling MG, Bastiaannet E, Pras B, Hoekstra HJ.
PMID: 30069502
Clin Transl Radiat Oncol. 2018 Mar 06;12:1-7. doi: 10.1016/j.ctro.2018.03.001. eCollection 2018 Aug.

BACKGROUND: The treatment approach for aggressive fibromatosis is changing. Although surgery is the mainstay in common practice, recent literature is reporting a more conservative approach. We compared the local control rate for surgery, surgery with radiotherapy, radiotherapy alone and...

Cite
Seinen JM, Niebling MG, Bastiaannet E, et al. Four different treatment strategies in aggressive fibromatosis: A systematic review. Clin Transl Radiat Oncol. 2018;12:1-7doi: 10.1016/j.ctro.2018.03.001.
Seinen, J. M., Niebling, M. G., Bastiaannet, E., Pras, B., & Hoekstra, H. J. (2018). Four different treatment strategies in aggressive fibromatosis: A systematic review. Clinical and translational radiation oncology, 121-7. https://doi.org/10.1016/j.ctro.2018.03.001
Seinen, Jojanneke M, et al. "Four different treatment strategies in aggressive fibromatosis: A systematic review." Clinical and translational radiation oncology vol. 12 (2018): 1-7. doi: https://doi.org/10.1016/j.ctro.2018.03.001
Seinen JM, Niebling MG, Bastiaannet E, Pras B, Hoekstra HJ. Four different treatment strategies in aggressive fibromatosis: A systematic review. Clin Transl Radiat Oncol. 2018 Mar 06;12:1-7. doi: 10.1016/j.ctro.2018.03.001. eCollection 2018 Aug. PMID: 30069502; PMCID: PMC6067057.
Copy Download .nbib Format: NLM
Current Understanding of the Structure and Function of Fungal Immunomodulatory Proteins.

Frontiers in nutrition

Liu Y, Bastiaan-Net S, Wichers HJ.
PMID: 33015115
Front Nutr. 2020 Aug 18;7:132. doi: 10.3389/fnut.2020.00132. eCollection 2020.

Fungal immunomodulatory proteins (FIPs) are a group of proteins found in fungi, which are extensively studied for their immunomodulatory activity. Currently, more than 38 types of FIPs have been described. Based on their conserved structure and protein identity, FIPs...

Cite
Liu Y, Bastiaan-Net S, Wichers HJ. Current Understanding of the Structure and Function of Fungal Immunomodulatory Proteins. Front Nutr. 2020;7:132doi: 10.3389/fnut.2020.00132.
Liu, Y., Bastiaan-Net, S., & Wichers, H. J. (2020). Current Understanding of the Structure and Function of Fungal Immunomodulatory Proteins. Frontiers in nutrition, 7132. https://doi.org/10.3389/fnut.2020.00132
Liu, Yusi, et al. "Current Understanding of the Structure and Function of Fungal Immunomodulatory Proteins." Frontiers in nutrition vol. 7 (2020): 132. doi: https://doi.org/10.3389/fnut.2020.00132
Liu Y, Bastiaan-Net S, Wichers HJ. Current Understanding of the Structure and Function of Fungal Immunomodulatory Proteins. Front Nutr. 2020 Aug 18;7:132. doi: 10.3389/fnut.2020.00132. eCollection 2020. PMID: 33015115; PMCID: PMC7461872.
Copy Download .nbib Format: NLM
Competing risks in quality and safety research: a framework to guide choice of analysis and improve reporting.

BMJ quality & safety

Marang-van de Mheen PJ, Putter H, Bastiaannet E, Bottle A.
PMID: 34535557
BMJ Qual Saf. 2021 Dec;30(12):1031-1037. doi: 10.1136/bmjqs-2021-012988. Epub 2021 Sep 17.

When comparing hospitals on their readmission rates as currently done in the Hospital Readmission and Reduction Program (HRRP) in the USA, should we include the competing risk of mortality after discharge, which precludes the readmission, in the analysis? Not...

Cite
Marang-van de Mheen PJ, Putter H, Bastiaannet E, et al. Competing risks in quality and safety research: a framework to guide choice of analysis and improve reporting. BMJ Qual Saf. 2021;30(12):1031-1037doi: 10.1136/bmjqs-2021-012988.
Marang-van de Mheen, P. J., Putter, H., Bastiaannet, E., & Bottle, A. (2021). Competing risks in quality and safety research: a framework to guide choice of analysis and improve reporting. BMJ quality & safety, 30(12), 1031-1037. https://doi.org/10.1136/bmjqs-2021-012988
Marang-van de Mheen, Perla J, et al. "Competing risks in quality and safety research: a framework to guide choice of analysis and improve reporting." BMJ quality & safety vol. 30,12 (2021): 1031-1037. doi: https://doi.org/10.1136/bmjqs-2021-012988
Marang-van de Mheen PJ, Putter H, Bastiaannet E, Bottle A. Competing risks in quality and safety research: a framework to guide choice of analysis and improve reporting. BMJ Qual Saf. 2021 Dec;30(12):1031-1037. doi: 10.1136/bmjqs-2021-012988. Epub 2021 Sep 17. PMID: 34535557.
Copy Download .nbib Format: NLM
Chemoradiation and Local Excision versus Total Mesorectal Excision for T2N0 Rectal Cancer: Comparison of Short- and Long-Term Outcomes from Two Prospective Studies.

Annals of surgery

Lynn PB, Van der Valk M, Claassen YHM, Shi Q, Widmar M, Bastiaannet E, Van de Velde C, Garcia-Aguilar J.
PMID: 34225302
Ann Surg. 2021 Jul 02; doi: 10.1097/SLA.0000000000005052. Epub 2021 Jul 02.

OBJECTIVE: Compare oncological long-term and short-term outcomes between patients with distal cT2N0 rectal cancer treated with chemoradiotherapy and local excision (CRT+LE) and patients treated with total mesorectal excision (TME).SUMMARY BACKGROUND DATA: Previous studies showed that CRT+LE is equivalent to...

Cite
Lynn PB, Van der Valk M, Claassen YHM, et al. Chemoradiation and Local Excision versus Total Mesorectal Excision for T2N0 Rectal Cancer: Comparison of Short- and Long-Term Outcomes from Two Prospective Studies. Ann Surg. 2021;doi: 10.1097/SLA.0000000000005052.
Lynn, P. B., Van der Valk, M., Claassen, Y. H. M., Shi, Q., Widmar, M., Bastiaannet, E., Van de Velde, C., & Garcia-Aguilar, J. (2021). Chemoradiation and Local Excision versus Total Mesorectal Excision for T2N0 Rectal Cancer: Comparison of Short- and Long-Term Outcomes from Two Prospective Studies. Annals of surgery, . https://doi.org/10.1097/SLA.0000000000005052
Lynn, Patricio B, et al. "Chemoradiation and Local Excision versus Total Mesorectal Excision for T2N0 Rectal Cancer: Comparison of Short- and Long-Term Outcomes from Two Prospective Studies." Annals of surgery vol. (2021). doi: https://doi.org/10.1097/SLA.0000000000005052
Lynn PB, Van der Valk M, Claassen YHM, Shi Q, Widmar M, Bastiaannet E, Van de Velde C, Garcia-Aguilar J. Chemoradiation and Local Excision versus Total Mesorectal Excision for T2N0 Rectal Cancer: Comparison of Short- and Long-Term Outcomes from Two Prospective Studies. Ann Surg. 2021 Jul 02; doi: 10.1097/SLA.0000000000005052. Epub 2021 Jul 02. PMID: 34225302.
Copy Download .nbib Format: NLM
Response to the Comment on "Long-term Prognosis After Elective Abdominal Aortic Aneurysm Repair is Poor in Women and Men".

Annals of surgery

Bulder RMA, Talvitie M, Bastiaannet E, Hamming JF, Hultgren R, Lindeman JHN.
PMID: 33351474
Ann Surg. 2021 Dec 01;274(6):e858. doi: 10.1097/SLA.0000000000004688.

No abstract available.

Cite
Bulder RMA, Talvitie M, Bastiaannet E, et al. Response to the Comment on "Long-term Prognosis After Elective Abdominal Aortic Aneurysm Repair is Poor in Women and Men". Ann Surg. 2021;274(6):e858doi: 10.1097/SLA.0000000000004688.
Bulder, R. M. A., Talvitie, M., Bastiaannet, E., Hamming, J. F., Hultgren, R., & Lindeman, J. H. N. (2021). Response to the Comment on "Long-term Prognosis After Elective Abdominal Aortic Aneurysm Repair is Poor in Women and Men". Annals of surgery, 274(6), e858. https://doi.org/10.1097/SLA.0000000000004688
Bulder, Ruth M A, et al. "Response to the Comment on "Long-term Prognosis After Elective Abdominal Aortic Aneurysm Repair is Poor in Women and Men"." Annals of surgery vol. 274,6 (2021): e858. doi: https://doi.org/10.1097/SLA.0000000000004688
Bulder RMA, Talvitie M, Bastiaannet E, Hamming JF, Hultgren R, Lindeman JHN. Response to the Comment on "Long-term Prognosis After Elective Abdominal Aortic Aneurysm Repair is Poor in Women and Men". Ann Surg. 2021 Dec 01;274(6):e858. doi: 10.1097/SLA.0000000000004688. PMID: 33351474.
Copy Download .nbib Format: NLM
Statin use is associated with a reduced incidence of colorectal cancer expressing SMAD4.

British journal of cancer

Ouahoud S, Jacobs RJ, Kodach LL, Voorneveld PW, Hawinkels LJAC, Weil NL, van Vliet B, Herings RM, van der Burg LRA, van Wezel T, Morreau H, Slingerland M, Bastiaannet E, Putter H, Hardwick JCH.
PMID: 34703008
Br J Cancer. 2021 Oct 26; doi: 10.1038/s41416-021-01604-6. Epub 2021 Oct 26.

BACKGROUND: Long-term use of statins is associated with a small reduced risk of colorectal cancer but their mechanism of action is not well understood. While they are generally believed to act on KRAS, we have previously proposed that they...

Cite
Ouahoud S, Jacobs RJ, Kodach LL, et al. Statin use is associated with a reduced incidence of colorectal cancer expressing SMAD4. Br J Cancer. 2021;doi: 10.1038/s41416-021-01604-6.
Ouahoud, S., Jacobs, R. J., Kodach, L. L., Voorneveld, P. W., Hawinkels, L. J. A. C., Weil, N. L., van Vliet, B., Herings, R. M., van der Burg, L. R. A., van Wezel, T., Morreau, H., Slingerland, M., Bastiaannet, E., Putter, H., & Hardwick, J. C. H. (2021). Statin use is associated with a reduced incidence of colorectal cancer expressing SMAD4. British journal of cancer, . https://doi.org/10.1038/s41416-021-01604-6
Ouahoud, Sarah, et al. "Statin use is associated with a reduced incidence of colorectal cancer expressing SMAD4." British journal of cancer vol. (2021). doi: https://doi.org/10.1038/s41416-021-01604-6
Ouahoud S, Jacobs RJ, Kodach LL, Voorneveld PW, Hawinkels LJAC, Weil NL, van Vliet B, Herings RM, van der Burg LRA, van Wezel T, Morreau H, Slingerland M, Bastiaannet E, Putter H, Hardwick JCH. Statin use is associated with a reduced incidence of colorectal cancer expressing SMAD4. Br J Cancer. 2021 Oct 26; doi: 10.1038/s41416-021-01604-6. Epub 2021 Oct 26. PMID: 34703008.
Copy Download .nbib Format: NLM
Chemoradiation and Local Excision versus Total Mesorectal Excision for T2N0 Rectal Cancer: Comparison of Short- and Long-Term Outcomes from Two Prospective Studies.

Annals of surgery

Lynn PB, Van der Valk M, Claassen YHM, Shi Q, Widmar M, Bastiaannet E, Van de Velde C, Garcia-Aguilar J.
PMID: 34225302
Ann Surg. 2021 Jul 02; doi: 10.1097/SLA.0000000000005052. Epub 2021 Jul 02.

OBJECTIVE: Compare oncological long-term and short-term outcomes between patients with distal cT2N0 rectal cancer treated with chemoradiotherapy and local excision (CRT+LE) and patients treated with total mesorectal excision (TME).SUMMARY BACKGROUND DATA: Previous studies showed that CRT+LE is equivalent to...

Cite
Lynn PB, Van der Valk M, Claassen YHM, et al. Chemoradiation and Local Excision versus Total Mesorectal Excision for T2N0 Rectal Cancer: Comparison of Short- and Long-Term Outcomes from Two Prospective Studies. Ann Surg. 2021;doi: 10.1097/SLA.0000000000005052.
Lynn, P. B., Van der Valk, M., Claassen, Y. H. M., Shi, Q., Widmar, M., Bastiaannet, E., Van de Velde, C., & Garcia-Aguilar, J. (2021). Chemoradiation and Local Excision versus Total Mesorectal Excision for T2N0 Rectal Cancer: Comparison of Short- and Long-Term Outcomes from Two Prospective Studies. Annals of surgery, . https://doi.org/10.1097/SLA.0000000000005052
Lynn, Patricio B, et al. "Chemoradiation and Local Excision versus Total Mesorectal Excision for T2N0 Rectal Cancer: Comparison of Short- and Long-Term Outcomes from Two Prospective Studies." Annals of surgery vol. (2021). doi: https://doi.org/10.1097/SLA.0000000000005052
Lynn PB, Van der Valk M, Claassen YHM, Shi Q, Widmar M, Bastiaannet E, Van de Velde C, Garcia-Aguilar J. Chemoradiation and Local Excision versus Total Mesorectal Excision for T2N0 Rectal Cancer: Comparison of Short- and Long-Term Outcomes from Two Prospective Studies. Ann Surg. 2021 Jul 02; doi: 10.1097/SLA.0000000000005052. Epub 2021 Jul 02. PMID: 34225302; PMCID: PMC8658950.
Copy Download .nbib Format: NLM
Can physical prehabilitation prevent complications after colorectal cancer surgery in frail older patients?.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

van der Hulst HC, Bastiaannet E, Portielje JEA, van der Bol JM, Dekker JWT.
PMID: 34127328
Eur J Surg Oncol. 2021 Nov;47(11):2830-2840. doi: 10.1016/j.ejso.2021.05.044. Epub 2021 Jun 03.

INTRODUCTION: Frail patients with colorectal cancer (CRC) are at increased risk of complications after surgery. Prehabilitation seems promising to improve this outcome and therefore we evaluated the effect of physical prehabilitation on postoperative complications in a retrospective cohort of...

Cite
van der Hulst HC, Bastiaannet E, Portielje JEA, et al. Can physical prehabilitation prevent complications after colorectal cancer surgery in frail older patients?. Eur J Surg Oncol. 2021;47(11):2830-2840doi: 10.1016/j.ejso.2021.05.044.
van der Hulst, H. C., Bastiaannet, E., Portielje, J. E. A., van der Bol, J. M., & Dekker, J. W. T. (2021). Can physical prehabilitation prevent complications after colorectal cancer surgery in frail older patients?. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 47(11), 2830-2840. https://doi.org/10.1016/j.ejso.2021.05.044
van der Hulst, Heleen C, et al. "Can physical prehabilitation prevent complications after colorectal cancer surgery in frail older patients?." European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology vol. 47,11 (2021): 2830-2840. doi: https://doi.org/10.1016/j.ejso.2021.05.044
van der Hulst HC, Bastiaannet E, Portielje JEA, van der Bol JM, Dekker JWT. Can physical prehabilitation prevent complications after colorectal cancer surgery in frail older patients?. Eur J Surg Oncol. 2021 Nov;47(11):2830-2840. doi: 10.1016/j.ejso.2021.05.044. Epub 2021 Jun 03. PMID: 34127328.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 29 entries